VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 36 filers reported holding VINCERX PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,720,447 | -21.5% | 1,703,413 | +1.0% | 0.48% | -20.9% |
| Q2 2023 | $2,193,018 | +25.0% | 1,686,937 | 0.0% | 0.61% | +19.3% |
| Q1 2023 | $1,754,414 | +2.0% | 1,686,937 | 0.0% | 0.51% | -6.4% |
| Q4 2022 | $1,720,676 | -24.8% | 1,686,937 | +1.7% | 0.55% | -40.5% |
| Q3 2022 | $2,288,000 | +4.5% | 1,658,199 | 0.0% | 0.92% | +9.8% |
| Q2 2022 | $2,189,000 | -66.2% | 1,658,199 | +2.5% | 0.84% | -57.4% |
| Q1 2022 | $6,473,000 | -60.7% | 1,618,199 | 0.0% | 1.96% | -57.5% |
| Q4 2021 | $16,489,000 | -37.0% | 1,618,199 | 0.0% | 4.62% | -41.9% |
| Q3 2021 | $26,166,000 | +24.5% | 1,618,199 | 0.0% | 7.95% | +28.1% |
| Q2 2021 | $21,020,000 | -32.7% | 1,618,199 | 0.0% | 6.21% | -39.5% |
| Q1 2021 | $31,231,000 | – | 1,618,199 | – | 10.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAGE RHINO CAPITAL LLC | 1,618,199 | $31,231,000 | 10.26% |
| Affinity Asset Advisors, LLC | 543,010 | $10,480,000 | 3.56% |
| ACUTA CAPITAL PARTNERS, LLC | 394,000 | $7,604,000 | 2.74% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $9,650,000 | 2.72% |
| Logos Global Management LP | 480,000 | $9,264,000 | 0.90% |
| Sio Capital Management, LLC | 105,000 | $2,027,000 | 0.41% |
| SABBY MANAGEMENT, LLC | 82,948 | $1,601,000 | 0.31% |
| Monashee Investment Management LLC | 99,999 | $1,930,000 | 0.30% |
| Ikarian Capital, LLC | 438,684 | $8,467,000 | 0.28% |
| RTW INVESTMENTS, LP | 500,000 | $9,650,000 | 0.15% |